Records containing: Rhabdoid Tumor of the Kidney

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-13
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
CLINICAL_TRIALS study record update · 2025-12-17
Phase 2 Proof of Concept Study of Nivolumab and Ipilimumab in Children and Young Adults With Relapsed or Refractory INI1-negative Cancers
CLINICAL_TRIALS study record update · 2025-03-25
Renal Tumors Classification, Biology, and Banking Study
CLINICAL_TRIALS study record update · 2019-03-05
Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
CLINICAL_TRIALS study record update · 2019-03-05
Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2018-08-07
Focal Adhesion Kinase Expression in Pediatric Renal Tumors
CLINICAL_TRIALS study record update · 2018-08-07
Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid Tumor (ATRT)
CLINICAL_TRIALS study record update · 2017-06-14
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
CLINICAL_TRIALS study record update · 2016-05-19
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative High-Risk Renal Tumor Project: Application of Array-Based Methods and Next Generation Sequencing to Identify Candidate Molecular Targets for High-Risk Wilms Tumors